UPMC study: Monoclonal antibody treatment reduces COVID effects
PITTSBURGH (TNS) — Real-time studies among UPMC covid-19 patients show that monoclonal antibody treatments “significantly decrease” hospitalization and death, researchers said Wednesday, and experts say they’re studying whether such treatments